AI Article Synopsis

  • The study investigates the methylation of five neuropeptide gene promoters as potential biomarkers for predicting recurrence and poor survival in head and neck squamous cell carcinoma (HNSCC).
  • The results show high rates of methylation among the neuropeptide genes, with a significant correlation between the number of methylated genes and reduced disease-free survival among patients.
  • The findings suggest that specific methylation patterns could serve as valuable prognostic indicators for patients with HNSCC, helping to better assess risk and tailor patient management.

Article Abstract

Background: Staging and pathological grading systems are convenient but imperfect predictors of recurrence in head and neck squamous cell carcinoma (HNSCC). Identifying biomarkers for HNSCC that will progress and cause death is a critical research area, particularly if the biomarker can be linked to selection of patients. Therefore, to identify potential alternative prognostic markers, we investigated the methylation status of five neuropeptide gene promoters. The promoter methylation status was determined by quantitative methylation-specific PCR in 230 cases of HNSCC; 58 hypopharynx, 45 larynx, 56 oropharynx, and 71 oral cavity tumor samples were studied.

Results: The somatostatin (), tachykinin precursor 1 (), hypocretin neuropeptide precursor (), neuropeptide Y (), and galanin () promoters were methylated in 84.3, 63.5, 32.6, 28.3, and 20.0%, respectively, of the samples. The mean number of methylated genes per sample was 2.29 (range, 0-5). Disease-free survival was lower in patients with 3-5 methylated genes than in those with 0-2 methylated genes (log-rank test,  = 0.007). In multivariate Cox proportional hazards analysis, and promoter methylation independently predicted recurrence (odds ratios 1.620, 95% confidence interval [CI] 1.018-2.578,  = 0.042, and odds ratios 1.692, 95% CI 1.063-2.694,  = 0.027, respectively). In patients with oral cancer, methylation showed the best correlation with poor survival (odds ratio 4.427, 95% CI 1.634-12.00,  = 0.003). Similar findings were observed for and in patients with laryngeal cancer and oropharyngeal cancer, respectively.

Conclusion: In this study, we demonstrated the methylation status of the neuropeptide-encoding genes , , , , and and its relationship with recurrence and survival in HNSCC. These methylation changes may serve as potential molecular markers for defining the risk and prognosis of HNSCC.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5896056PMC
http://dx.doi.org/10.1186/s13148-018-0485-0DOI Listing

Publication Analysis

Top Keywords

methylation status
12
methylated genes
12
head neck
8
promoter methylation
8
odds ratios
8
methylation
6
hnscc
5
neuropeptide
4
neuropeptide genes
4
genes powerful
4

Similar Publications

Clear cell renal cell carcinoma (ccRCC) is a highly malignant tumor characterized by a significant propensity for recurrence and metastasis. DNA methylation has emerged as a critical epigenetic mechanism with substantial utility in cancer diagnosis. In this study, multi-omics data were utilized to investigate the target genes regulated by the transcription factor MYC-associated zinc finger protein (MAZ) in ccRCC, leading to the identification of thymidine phosphorylase (TYMP) as a gene with notably elevated expression in ccRCC.

View Article and Find Full Text PDF

Intrauterine growth restriction (IUGR) is a risk factor for postnatal cardiovascular, metabolic, and psychiatric disorders. In most IUGR models, placental dysfunction that causes reduced 11β-hydroxysteroid dehydrogenase 2 (11βHSD2) activity, which degrades glucocorticoids (GCs) in the placenta, resulting in fetal GC overexposure. This overexposure to GCs continues to affect not only intrauterine fetal development itself, but also the metabolic status and neural activity in adulthood through epigenetic changes such as microRNA change, histone modification, and DNA methylation.

View Article and Find Full Text PDF

Neuroblastoma is a common malignant tumor in childhood that seriously endangers the health and lives of children, making it essential to find effective prognostic markers to accurately predict their clinical outcomes. The development of high-throughput technology in the biomedical field has made it possible to obtain multi-omics data, whose integration can compensate for missing or unreliable information in a single data source. In this study, we integrated clinical data and two omics data, i.

View Article and Find Full Text PDF

Plasma, milk and tissue samples were collected from 30 dairy cattle (0.4 to 8.9 years of age) with lifetime exposures to perfluoroalkyl substances (PFAS) removed from a PFAS-contaminated farm and provided PFAS-free feed and water.

View Article and Find Full Text PDF

Freshwater quality, and the impacts of farming practice on drinking water supplies, are of concern in many countries and time-limited catchment management interventions are commonly used to improve water quality. However, ending such schemes may result in practice reversion. This study adopts an interdisciplinary approach combining evidence from water quality monitoring data with a behavioural study of farmers to explore changes in land use practice with reference to the pesticide MCPA (2-methyl-4-chlorophenoxyacetic acid) following a catchment-based management scheme delivered in the cross-border Derg catchment in Northern Ireland/Ireland between 2018 and 2021.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!